Study Links Parkinson's in Women to Alzheimer's Pathology

Researchers examining 230 autopsy cases found women with Parkinson's disease showed higher rates of Alzheimer's-related amyloid pathology.

Updated on Nov. 6, 2026 in Alzheimer’s

Close view of a microscope lens focused on a thin tissue slide in a bright laboratory with desert daylight beyond the window.
Researchers found women with Parkinson's disease dementia showed higher rates of Alzheimer's-related amyloid pathology than men in a study of 230 autopsy cases. AI Illustration. Upload story photo >

A study of 230 autopsy cases found that women with Parkinson's disease dementia had higher rates of Alzheimer's amyloid pathology than men. The research was published in the Journal of Parkinson's Disease and conducted through an Arizona aging and neurodegenerative disorders program.

Why it matters

The findings suggest sex may influence which brain changes contribute to dementia in Parkinson's patients. Researchers say this could help identify new areas for treatment research.

The study compared autopsy findings across 230 Parkinson's cases, a post-mortem design that shows brain pathology but not how it developed during life. Whether amyloid-targeting treatments would work for these patients has not been tested in the reported research.

The players

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

A brain bank research program in Arizona that collects donated brains to study aging and neurodegenerative diseases.

The details

Researchers performed autopsies on brains donated through the Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program and compared findings between sexes. No difference was found between women and men in tau pathology or in levels of cognitive impairment.

Timeline

  1. Article on the study findings published November 6, 2026.

Health Landscape

The study adds to a growing body of research on sex differences in neurodegenerative disease, which has historically been underrepresented in clinical trials. Its findings point toward potential targets for future work on dementia in Parkinson's patients.

For people living with Parkinson's disease, the findings do not change current treatment options. Any clinical application would depend on future trials testing whether anti-amyloid medications help this group.

The takeaway

Sex may shape how Parkinson's and Alzheimer's-related brain changes overlap, which could guide more targeted research. Readers should watch for follow-up trials before drawing conclusions for treatment.

Further reading

For related context, see the Alzheimer's coverage on Wisevoter.

Source note: This article includes information reported by News-Medical.